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PLOS Medicine Debate
The Case against a Smoker’s License
Jeff Collin*
Global Public Health Unit, School of Social & Political Science, University of Edinburgh, Edinburgh, Scotland, United Kingdom
Background to the debate: Tobacco continues to kill
millions of people around the world each year and its use
is increasing in some countries, which makes the need for
new, creative, and radical efforts to achieve the tobacco
control endgame vitally important. One such effort is
discussed in this PLOS Medicine Debate, where Simon
Chapman presents his proposal for a ‘‘smoker’s license’’
and Jeff Collin argues against. Chapman sets out a case
for introducing a smart card license for smokers designed
to limit access to tobacco products and encourage
cessation. Key elements of the smoker’s license include
smokers setting daily limits, financial incentives for
permanent license surrender, and a test of health risk
knowledge for commencing smokers. Collin argues
against the proposal, saying that it would shift focus
away from the real vector of the epidemic—the tobacco
industry—and that by focusing on individuals it would
censure victims, increase stigmatization of smokers, and
marginalize the poor.
Despite its many successes, the need for tobacco control
advocates to think outside the box and explore radical new
options remains compelling. As always it is difficult to know
whether to be more impressed by the scale of recent legislative
achievements in driving change, or to despair at the widespread
persistence of damaging behaviours and devastating health
impacts. For all the progress made, with increasing numbers of
countries implementing the diverse evidence-based measures
recommended by the WHO Framework Convention on Tobacco
Control (FCTC), no state has managed to reduce smoking
prevalence to an extent that anyone in public health might regard
as tolerable. The attainment of a tobacco-free future, so critical to
any global conception of health for all, remains elusive. The need
to rethink and extend tobacco control’s playbook is therefore clear,
and the recent upsurge of interest in endgame strategies [1–3] is
both welcome and necessary.
In this context, Simon Chapman’s typically powerful advocacy
of the case for a smoker’s license in this issue of PLOS Medicine
offers an important contribution to emerging debates [4]. While it
seems reasonable to hypothesize that such a scheme could further
reduce tobacco consumption in some countries, the notion of
licensing smokers raises significant strategic concerns and high-
lights broader questions of principle with which tobacco control
must engage. In searching for new measures to drive towards an
endgame, Chapman’s proposal highlights the importance of
reflecting not only on what new legislative wins might be within
reach for tobacco control advocates, but to more carefully
delineate the ethical limits of pursuing such goals.
In critiquing the smoker’s license proposal, I should acknowl-
edge that in some specific national contexts its adoption may be
comparatively unproblematic (Chapman notes its similarities with
ideas under discussion in Singapore), while there are clearly
context-specific aspects to the objections outlined below. In
countries where digital ID cards are routinely carried or objections
to authorities holding data are limited, for example, linking
tobacco purchases to such cards may be largely unproblematic
technically or politically; at least some of the data envisaged under
this scheme may be generated; and the idea of progressively raising
the legal age of purchase merits wider consideration.
In highlighting the problems associated with the ubiquity of
tobacco retail outlets, Chapman importantly recognises the
continuing comparative neglect of supply-side issues. It is indeed
an historical absurdity that so dangerous a product should be so
readily available, and the policy implications of ‘‘tobacco sale
(being) subject to trivial controls compared with other dangerous
products’’ merit exploration. While point-of-sale display bans [5,6]
are beginning to focus attention on regulating the retail
environment, it is disappointing that more sustained attention
hasn’t yet been given to models of controlling availability. In this
respect, at least, Chapman’s analogy with restricted access to
medicines has some merit, while studies of the hours of sale and
density of outlets for alcohol suggest that measures to reduce the
availability of harmful products can contribute effectively to public
health strategies [7,8]. But this literature also suggests that the
ubiquity of tobacco products can be challenged by rather different
routes than that specified in the smoker’s license scheme, and
Chapman’s proposal is curious in seeking to reshape the structure
of retailing environment via measures that are so starkly targeted
towards consumers.
It is against this radical shift of regulatory attention to a direct
focus on smokers that fundamental objections to the scheme
should be directed. To date the tobacco control agenda has been
principally concerned with regulating the conduct of the tobacco
industry, on the basis of an understanding that effectively curbing
this industrial epidemic [9] is best achieved via actions that tackle
the disease vector [10]. The unique centrality of this perspective
within tobacco control, embedded in the WHO FCTC, has been
crucial to recent successes and contrasts starkly with the continuing
scope for partnership with industry that widely typifies alcohol and
obesity policies at national and international levels [11]. It also
indicates a policy agenda that is far from exhausted. From a global
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perspective, the challenges of effectively implementing the FCTC
centre on industry opposition, exacerbated by tensions between
public health goals and trade liberalisation via the World Trade
Organisation and, increasingly, bilateral agreements [12]. Even
among those comparatively successful countries to which Chap-
man directs his proposal, key priorities include the development of
approaches to taxation that can more effectively target industry
profitability, ensuring that health objectives aren’t undermined via
product innovation in smokeless tobacco and nicotine delivery
devices such as e-cigarettes, and building on progress in Australia
to ensure the adoption and implementation of generic packaging.
There is also an important need for more creative thinking in how
we regulate the industry, which should centre on changing a
system of manufacture and promotion of such harmful products
centred on the corporation, an institution that is staggeringly ill-
suited to such roles when viewed from a public health perspective
[13,14].
It is particularly important that the search for innovative new
strategies doesn’t rather create gifts for the tobacco industry, which
this one undoubtedly would. It is arguably no more radical a
proposal for social change than that represented by Ireland’s
legislation for smoke-free work places less than a decade ago. Yet
while the implications of such change for smokers have been
profound, such reforms have been recognised as legitimate and
attracted broad consent since they effectively reconciled innovative
health protection with broader norms. Smoke-free policies have
been recognised and understood as unambiguously liberal
measures rather than authoritarian intrusions on personal
freedom. In advancing a case focused on the protection of non-
smokers, workers, and children, such legislation conforms to JS
Mill’s classic formulation of the harm principle in On Liberty: ‘‘(t)he
only purpose for which power can be rightfully exercised over any
member of a civilized community, against his will, is to prevent
harm to others’’ [15]. The coherence of such positions has been of
great strategic importance, not least in convincingly rebutting the
oft-repeated charges of ‘‘health fascism’’ made by tobacco
companies and their front groups [16].
The authoritarian connotations of the smoker’s license would
inevitably meet with broad opposition. In the United Kingdom,
for example, successive governments have failed to introduce
identity cards. If it’s very difficult to envisage health advocates
securing support for a comparable scheme on the basis of a public
health rationale, it is still harder to see why they should wish to.
In constituting ‘‘an explicitly user-focused form of regulation’’
[4], Chapman’s proposal to license smokers has the potential to
dramatically exacerbate their stigmatization. That many smokers
would feel that they were ‘‘being treated like registered addicts’’
[4] seems inevitable, and indeed is central to the scheme’s design.
Chapman is correct to note that many industry- and product-
focused measures do directly affect smokers, but he acknowledges
that what is being proposed here is qualitatively different. Given
the pronounced social gradient of smoking, core tobacco control
measures have long had implications for the poor (most obviously
via the use of taxation to reduce consumption); a distinguishing
feature of this scheme is that, in effect, it would be censuring the
poor.
In developing new strategies to further reduce tobacco
consumption, we need to seek to better manage the central
tension between smoking and stigma. While public health
generally sees stigmatization as inimical to its goals, tobacco
control has demonstrated the capacity of ‘‘efforts to denormalize,
marginalize and stigmatize smoking’’ to ‘‘further the goals of
public health’’ [17]. But this does not mean that tobacco control
should always view increased stigmatization as a price worth
paying for reduced consumption. The proposal to require licenses
will inevitably be widely perceived as demeaning, onerous, and
punitive, and in explicitly targeting smokers would dramatically
exacerbate the sense that smoking ‘‘just has that sort of feel about
it, a leper’’ [18].
A fundamental challenge confronting any endgame strategy is
that the move towards a tobacco-free society should address the
social determinants of health and promote equity and social
justice. The proposal for a smoker’s license should be rejected as
failing this challenge.
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